Sign Up to like & get
recommendations!
0
Published in 2017 at "Urology"
DOI: 10.1016/j.urology.2017.05.035
Abstract: A 47-year-old man presented to the urology department with visible hematuria. He was found to have a high-grade non-muscle-invasive transitional cell carcinoma of the bladder and was subsequently treated with intravesical Bacillus Calmette-Guérin instillations. On…
read more here.
Keywords:
high grade;
muscle invasive;
non muscle;
bacillus calmette ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000008757
Abstract: Rationale: Recently, drug-related myasthenia gravis (MG) has received attention, because the number of reported cases involving MG associated with immune checkpoint inhibitors, a new immunotherapy, is increasing. We present a case involving the new onset…
read more here.
Keywords:
bacillus calmette;
calmette guerin;
myasthenia gravis;
new onset ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "International Journal of Urology"
DOI: 10.1111/iju.14139
Abstract: To determine the initial response to intravesical bacillus Calmette–Guérin and the 3‐year recurrence rate of high‐risk non‐muscle‐invasive bladder cancer in patients who have asymptomatic bacteriuria.
read more here.
Keywords:
asymptomatic bacteriuria;
response intravesical;
bacillus calmette;
calmette rin ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Urology"
DOI: 10.1111/iju.14933
Abstract: To investigate current patterns and outcomes of intravesical bacillus Calmette–Guérin treatment in Japanese patients with bladder cancer, including the proportion of patients completing induction therapy, and time to subsequent treatments.
read more here.
Keywords:
calmette rin;
intravesical bacillus;
japanese patients;
bacillus calmette ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "International Journal of Urology"
DOI: 10.1111/iju.70045
Abstract: To demonstrate the diagnostic performance of photodynamic diagnosis (PDD) for bladder cancer using oral 5‐aminolaevulinic acid in patients with or without a history of intravesical Bacillus Calmette‐Guérin (BCG) therapy, and to investigate the potential causes…
read more here.
Keywords:
photodynamic diagnosis;
history;
intravesical bacillus;
history intravesical ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Journal of Medical Case Reports"
DOI: 10.1186/s13256-023-04310-4
Abstract: Intravesical Bacillus Calmette–Guérin (BCG) is used as a standard adjuvant therapy for non-muscle invasive urothelial cancer. Most patients tolerate the treatment well, with mild side effects. Systemic complications are extremely rare, occur due to BCG…
read more here.
Keywords:
granulomatous myocarditis;
therapy;
intravesical bacillus;
case ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Internal Medicine"
DOI: 10.2169/internalmedicine.9102-17
Abstract: Mycobacterium bovis infection after intravesical Bacillus Calmette-Guérin (BCG) therapy is rare. A 65-year-old Japanese man with history of bladder cancer and intravesical BCG therapy, presented with low-grade fever. An aneurysm with perianeurysmal fluid was suspected…
read more here.
Keywords:
mycobacterium bovis;
bovis;
bacillus calmette;
calmette rin ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Oncology Research"
DOI: 10.32604/or.2025.061812
Abstract: Objective To determine the safety and the role of modulating cytokines and proteases in the immune response to intravesical Bacillus Calmette-Guérin (BCG) when primed with systemic intradermal BCG. Methods Phase 1 and mechanistic longitudinal, prospective,…
read more here.
Keywords:
bcg;
calmette rin;
intravesical bacillus;
bladder ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of clinical imaging science"
DOI: 10.4103/2156-7514.230280
Abstract: Intravesical Bacillus Calmette–Guerin (BCG) immunotherapy is a proven, effective treatment for intermediate- and high-risk non-muscle-invasive bladder cancer. Minor side effects are common and expected but systemic effects can occur in
read more here.
Keywords:
bladder;
muscle invasive;
non muscle;
bacillus calmette ... See more keywords